U.S. Breast Cancer Brachytherapy Market Size & Outlook
U.S. breast cancer brachytherapy market, 2015-2027 (US$M)
Related Markets
U.S. breast cancer brachytherapy market highlights
- The U.S. breast cancer brachytherapy market generated a revenue of USD 26.9 million in 2018 and is expected to reach USD 44.4 million by 2027.
- The U.S. market is expected to grow at a CAGR of 5.7% from 2019 to 2027.
- In terms of segment, high dose rate (hdr) was the largest revenue generating technology in 2018.
- High Dose Rate (HDR) is the most lucrative technology segment registering the fastest growth during the forecast period.
Breast cancer brachytherapy market data book summary
| Market revenue in 2018 | USD 26.9 million |
| Market revenue in 2027 | USD 44.4 million |
| Growth rate | 5.7% (CAGR from 2018 to 2027) |
| Largest segment | High dose rate (hdr) |
| Fastest growing segment | High Dose Rate (HDR) |
| Historical data | 2015 - 2017 |
| Base year | 2018 |
| Forecast period | 2019 - 2027 |
| Quantitative units | Revenue in USD million |
| Market segmentation | High Dose Rate (HDR), Low Dose Rate (LDR) |
| Key market players worldwide | Eckert & Ziegler Bebig SA, Elekta AB ADR, Siemens Healthineers AG ADR, Icad Inc, Hologic Inc, Merit Medical Systems Inc |
Other key industry trends
- In terms of revenue, U.S. accounted for 46.1% of the global breast cancer brachytherapy market in 2018.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2027.
- In North America, U.S. breast cancer brachytherapy market is projected to lead the regional market in terms of revenue in 2027.
- Canada is the fastest growing regional market in North America and is projected to reach USD 5.4 million by 2027.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Breast Cancer Brachytherapy Market Scope
Breast Cancer Brachytherapy Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
U.S. breast cancer brachytherapy market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to breast cancer brachytherapy market will help companies and investors design strategic landscapes.
High dose rate (hdr) was the largest segment with a revenue share of 66.17% in 2018. Horizon Databook has segmented the U.S. breast cancer brachytherapy market based on high dose rate (hdr), low dose rate (ldr) covering the revenue growth of each sub-segment from 2015 to 2027.
- U.S. Breast Cancer Brachytherapy Technology Outlook (Revenue, USD Million, 2015-2027)
- High Dose Rate (HDR)
- Low Dose Rate (LDR)
Reasons to subscribe to U.S. breast cancer brachytherapy market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. breast cancer brachytherapy market databook
-
Our clientele includes a mix of breast cancer brachytherapy market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. breast cancer brachytherapy market, including forecasts for subscribers. This country databook contains high-level insights into U.S. breast cancer brachytherapy market from 2015 to 2027, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. breast cancer brachytherapy market size, by technology, 2015-2027 (US$M)
U.S. Breast Cancer Brachytherapy Market Share, 2018 & 2027 (US$M)
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
